Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences
May 09 2024 - 4:58PM
Business Wire
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that
it will participate at three upcoming investor conferences:
Citizens JMP Life Sciences Conference
Fireside Chat: Tuesday, May 14, 2024 at 1:30 p.m. Eastern Time in
New York, NY
2024 RBC Capital Markets Global Healthcare
Conference Fireside Chat: Wednesday, May 15, 2024 at 11:30 a.m.
Eastern Time in New York, NY
BofA Securities Health Care Conference
Fireside Chat: Wednesday, May 16, 2024 at 12:20 p.m. Eastern Time
in Las Vegas, NV
Live webcasts of each fireside chat will be accessible on the
company’s website, Acadia.com, under the investors section and an
archived recording will be available on the website for
approximately one month following each presentation.
About Acadia Pharmaceuticals
Acadia is advancing breakthroughs in neuroscience to elevate
life. For 30 years we have been working at the forefront of
healthcare to bring vital solutions to people who need them most.
We developed and commercialized the first and only FDA-approved
drug to treat hallucinations and delusions associated with
Parkinson’s disease psychosis and the first and only FDA-approved
drug for the treatment of Rett syndrome. Our clinical-stage
development efforts are focused on Prader-Willi syndrome,
Alzheimer’s disease psychosis and multiple other programs targeting
neuropsychiatric symptoms in central nervous system disorders. For
more information, visit us at Acadia.com and follow us on LinkedIn
and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240507861038/en/
Investor Contact: Acadia Pharmaceuticals Inc. Al Kildani (858)
261-2872 ir@acadia-pharm.com
Acadia Pharmaceuticals Inc. Jessica Tieszen (858) 261-2950
ir@acadia-pharm.com
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From Apr 2024 to May 2024
Acadia Pharmaceuticals (NASDAQ:ACAD)
Historical Stock Chart
From May 2023 to May 2024